Package Insert (PI) Table

Please note the following when using Package Inserts from this web site:

The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both domestic and international.   The drug labeling, and other information is as obtainable by DAIDS and its content has neither been altered nor verified by DAIDS; as such, this content may not be Section 508 compliant.  If in the use of adaptive equipment, you encounter problems accessing the content, DAIDS will assist access through equivalent facilitation.  Please e-mail for assistance.


Drug Name Sort descending Drug Company PI Date Risk List Available?
Isoniazid Sandoz Inc. October 2018
Isoniazid Teva Pharmaceuticals USA, Inc. March 2018
Isoniazid Macleods Pharmaceuticals Ltd August 2015
Lamivudine (Epivir) GlaxoSmithKline September 2020 YES
Ledipasvir/Sofosbuvir (Harvoni) Gilead November 2019
Letermovir (Prevymis) - New Merck February 2021
Levonorgestrel Northstar Rx April 2018
Lopinavir/Ritonavir (Kaletra) AbbVie December 2019 YES
Medroxyprogesterone Acetate (DEPO-PROVERA CI) Pfizer January 2017
Peginterferon alfa 2b (Pegintron) Merck January 2019
Pitavastatin (Livalo) - New Kowa September 2020
Pravastatin Sandoz December 2006
Pyrazinamide Macleods Pharmaceuticals Limited May 2014
Raltegravir (Isentress) Merck July 2020 YES
Ribavirin Aurobindo Pharma Limited October 2018
Rifabutin Greenstone LLC April 2018
Rifabutin (Mycobutin) Pfizer April 2018
Rifampicin Macleods Pharmaceuticals Limited December 2018
Rifampin Lannett Company Inc. September 2019
Rifampin/Isoniazid/Pyrazinamide/Ethambutol (Rifafour e-276) Sanofi-Aventis April 2013